Chimerix IPO Advisory
Share this IPO Profile:
Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on Chimerix, and our comprehensive analysis, click "
Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Chimerix | CMRX - |
$13.00-$15.00 |
$14.00 |
$15.14 | 7.32 million | 4/11/2013 |
Morgan Stanley, J.P. Morgan |
Co-Manager(s): Cowen & Co., Piper Jaffray, Stifel |
Health Care |
Filing(s): Filed 2013-03-08
|
Chimerix Quote & Chart - Click for current quote -
CMRX
About Chimerix (adapted from Chimerix prospectus):
They are a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CMRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved